After the discovery of a new gene therapy for Huntington's, a devastating brain disease, Datshiane Navanayagam talks to one of the women in the UK who worked on it and a biologist from India who's made recent discoveries that could improve treatment for TB, which still kills over a million people globally each year. Anne Rosser is Professor of Clinical Neuroscience at Cardiff University, combining both academic and clinical work specialising in patients with Huntington’s Disease. Huntington’s is an inherited condition caused by a faulty gene which stops the brain working properly, affecting mobility, learning, thinking and emotions. Anne also directs the Brain Repair Group in Cardiff. Paridhi Sukheja is lead biologist for Tuberculosis drug discovery at Calibr-Skaggs Institute at Scripps Research in the US – a nonprofit research institute looking at drug discovery and treatments for diseases. TB is one of the world’s deadliest infectious diseases and, while widely treatable, it still kills 1.2 million people a year. Part of this is due to increasingly drug-resistant strains of the disease. Paridhi's work has been instrumental in the discovery of a potential new treatment for TB, including drug-resistant strains. Produced by Jane Thurlow (Image: (L) Paridhi Sukheja credit Nick Cusato. (R), Anne Rosser courtesy Anne Rosser.)
